Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aratana Therapeutics Inc (NASDAQ:PETX)

2.74
BATS BZX Real-Time Price
As of 3:51pm ET
 +0.06 / +2.24%
Today’s Change
2.60
Today|||52-Week Range
20.63
-50.90%
Year-to-Date

Today’s Trading

Previous close2.68
Today’s open2.70
Day’s range2.60 - 2.98
Volume380,405
Average volume (3 months)578,533
Market cap$93.8M
Dividend yield--
Data as of 3:51pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)-233.33%
Earnings growth (this year)-54.22%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+523.58%
P/E ratioNM
Price/Sales691.60
Price/Book0.50

Competitors

 Today’s
change
Today’s
% change
ALIMAlimera Sciences Inc-0.02-0.95%
ARGSArgos Therapeutics I...-0.58-12.80%
LIFEaTyr Pharma Inc-0.10-2.55%
PRQRProQR Therapeutics N...+0.24+6.09%
Data as of 3:54pm ET, 02/10/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$767.0K
Annual profit (last year)-$38.8M
Net profit margin-5,060.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
CFO, Treasurer &
Head-Investor Relations
Craig A. Tooman
Corporate headquarters
Leawood, Kansas

Forecasts

Partner Offers